ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,010.00
-100.00 (-4.74%)
At close: Aug 11, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 54.17 billion as of August 11, 2026. Its market cap has increased by 32.35% in one year.
Market Cap
54.17B
Enterprise Value
60.93B
Revenue
12.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,010.00
ChartMarket Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 54.17B, an increase of 113.73%. That is a compound annual growth rate of 12.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 54.17B | 63.11% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| QuadMedicine | 69.81B |
| NovMetaPharma | 66.65B |
| J2KBIO | 65.43B |
| KoBioLabs | 64.86B |
| Naturalendo Tech | 61.25B |
| TegoScience | 60.29B |
| Aptamer Sciences | 57.99B |
| Psomagen | 57.52B |